Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine

Author： Wu N   Chen S   Boulanger L   Rao P   Zhao Y  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.6, 2011-06, pp. : 1131-1139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators

By  

PAIN PRACTICE, Vol. 18, Iss. 2, 2018-02 ,pp. : 154-169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis

By Nasr Samya Z.  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 801-808

Informa Healthcare

Access to resources Recommend Favorite

Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia

By Sun Peter   Zhao Yang   Zhao Zhenxiang   Watson Peter  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1793-1801

Informa Healthcare

Access to resources Recommend Favorite

Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia

By Lang Kathleen  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 997-1006

Informa Healthcare

Access to resources Recommend Favorite

Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies

By Zhao Y.   Wu N.   Chen S.   Boulanger L.   Police R.L.   Fraser K.  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2147-2156

Informa Healthcare

Access to resources Recommend Favorite